Skip to content
Tenfell
Awarded contract
Published 24 May 2023

NHS National Generics Pharmaceuticals Transition 2023_1

NHS England · London

Key facts

Awarded
04 May 2023
Contract starts
31 Jul 2023
Contract ends
31 Jan 2025
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 30 suppliers

SupplierValue
Consilient Health Ltd—
Crescent Pharma Limited—
Dr Reddy's Laboratories (UK) Ltd—
Teva UK Ltd—
Aventis Pharma Ltd T/A Sanofi—
Sandoz Ltd—
Thornton & Ross Ltd—
Wockhardt UK Limited—
Accord-UK Ltd—
Sun Pharma UK Ltd—
Zentiva Pharma UK Ltd—
Amarox Limited—
Aristo Pharma Limited—
Brown & Burk UK Ltd—
Day Lewis Medical Ltd—
Drugsrus Ltd—
Eramol (UK) Ltd—
Fontus Health Ltd—
Ipca Laboratories UK Ltd—
medac Pharma LLP—
Milpharm Ltd/aurobinbdo—
Neuraxpharm UK Ltd—
Relonchem Ltd—
Resolution Chemicals Limited—
Roma Pharmaceuticals Limited—
Strandhaven Ltd t/a Somex Pharma—
Syri Limited (T/A Thame Laboratories)—
Thea Pharmaceuticals Limited—
Tillomed Laboratories ltd—
Waymade PLC—

Description

Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1 Offer reference number: CM/PHG/22/5666 FIND A TENDER (FTS) Reference number: 2023/S 000-000801

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. CM/PHG/22/5666/00 - Transition Products: CESW 01/08/2023 - 31/01/2024 (6 months) NWLN 01/08/2023 - 31/01/2025 (18 months) LSNE 01/08/2023 - 31/05/2024 (10 months)

CM/PHG/22/5666/01 - Orals (plus non-parenteral) Products: All regions: 01/08/2023 to 31/05/2024 (10 Months)

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.